Royalty Pharma PLC (Class A) Live Stock Price Today, Share Analysis and Chart

Name: Royalty Pharma plc - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Royalty Pharma plc - Ordinary Shares - Class A
Rating: 2.420027625
Author: Trendlyne DVM scores

Mid-range Performer

about

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products...

38.26 0.17 (0.45%)

59.09% Gain from 52W Low

3.4M

XNAS Volume

XNAS 10 Dec, 2025 4:30 PM (EST)

Medium Financial Strength

44.4 / 100

Mid Valuation

46.3 / 100

Technically Neutral

58.4 / 100

Mid-range Performer These stocks average quality, financial and technical aspects make them being considered by the investor who are not looking for high risk stocks. View Similar Embed DVM

1Yr Price target upside is 20%

9 analysts

Royalty Pharma PLC (Class A) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Royalty Pharma PLC (Class A) Live Stock Price Today, Share Analysis and Chart

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products...

59.09% Gain from 52W Low

SWOT Analysis

Royalty Pharma PLC (Class A) Live Price Chart